Abstract
Background A 56-year-old woman was referred to a neurogenetic clinic with a history of stiffness and transient weakness. A previous needle electromyogram had confirmed the presence of myotonia, but a muscle biopsy had revealed no evidence of dystrophy.
Investigations Neurological examination, electrophysiological studies and genetic testing.
Diagnosis Recessive myotonia congenita (Becker's disease).
Management Explanation of the nature of the disease and treatment with mexiletine 200 mg twice daily.
References
Colding-Jorgensen E (2003) Decrement of compound muscle action potential is related to mutation type in myotonia congenita. Muscle Nerve 27: 449–455
Colding-Jorgensen E (2005) Phenotypic variability in myotonia congenita. Muscle Nerve 32: 19–34
Becker PE (1977) Syndromes associated with myotonia: clinical-genetic classification. In Pathogenesis of human muscular dystrophies, 699–703 (Ed. Rowland LP) New York: Excerpta Medica
Davies NP and Hanna MG (2001) The skeletal muscle channelopathies: basic science, clinical genetics and treatment. Curr Opin Neurol 14: 539–551
Graves TD and Hanna MG (2005) Neurological channelopathies. Postgrad Med J 81: 20–32
Deymeer F et al. (1998) Transient weakness and compound muscle action potential decrement in myotonia congenita. Muscle Nerve 21: 1334–1337
Lehmann-Horn F and Rudel R (1996) Channelopathies: the nondystrophic myotonias and periodic paralyses. Semin Pediatr Neurol 3: 122–139
Mankodi A et al. (2002) Expanded CUG repeats trigger aberrant splicing of CLC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscles in myotonic dystrophy. Mol Cell 10: 35–44
Streib EW (1987) AAEE minimonograph #27: differential diagnosis of myotonic syndromes. Muscle Nerve 10: 603–615
Jurkat-Rott et al. (2002) Skeletal muscle channelopathies. J Neurol 249: 1493–1502
Ptacek L (1998) The familial periodic paralyses and nondystrophic myotonias Am J Med 105: 58–70
Fournier E et al. (2004) Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol 56: 650–661
Subramony SH et al. (1983) Distinguishing paramyotonia congenita and myotonia congenita by electromyography. Muscle Nerve 6: 374–379
Odermatt A (1996) Mutations in the gene-encoding SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+ ATPase, are associated with Brody disease. Nat Genet 14: 191–194
Newsom-Davis J (2004) Neuromyotonia. Rev Neurol (Paris) 160 (5 Pt 2): S85–S89
Pusch M (2002) Myotonia caused by mutations in the muscle chloride channel gene CLCN1. Hum Mutat 19: 423–434
Meola G and Sansone V (2004) Treatment in myotonia and periodic paralysis. Rev Neurol (Paris) 160 (5 Pt 2): S55–S69
Farbu E et al. (2003) Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders. Acta Anaesthesiol Scand 47: 630–634
Preston DC and Shapiro BE (1998) Myotonic muscle disorders and periodic paralysis syndromes. In Electromyography and Neuromuscular Disorders: Clinical-Electrophysiologic Correlations, 541–559, Newton: Butterworth-Heinemann
Acknowledgements
We thank Dr Sternberg from the Groupe Hospitalier de la Pitié-Salpêtrière for performing the genetic testing in this case.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Chrestian, N., Puymirat, J., Bouchard, JP. et al. Myotonia congenita—a cause of muscle weakness and stiffness. Nat Rev Neurol 2, 393–399 (2006). https://doi.org/10.1038/ncpneuro0239
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0239
- Springer Nature Limited
This article is cited by
-
Becker congenital myotonia in black African with molecular findings
Egyptian Journal of Medical Human Genetics (2022)
-
Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel
BMC Neurology (2021)